Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
2001 1
2003 2
2004 1
2005 2
2007 1
2008 3
2009 4
2010 2
2011 5
2012 6
2013 12
2014 8
2015 15
2016 9
2017 22
2018 29
2019 22
2020 21
2021 23
2022 24
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Results by year

Filters applied: . Clear all
Page 1
Oral agents in multiple sclerosis.
Lorefice L, Fenu G, Frau J, Coghe GC, Marrosu MG, Cocco E. Lorefice L, et al. Among authors: frau j. Antiinflamm Antiallergy Agents Med Chem. 2015;14(1):15-25. doi: 10.2174/1871523014999150415130224. Antiinflamm Antiallergy Agents Med Chem. 2015. PMID: 25924620 Review.
Monoclonal antibodies: a target therapy for multiple sclerosis.
Lorefice L, Fenu G, Frau J, Coghe G, Marrosu MG. Lorefice L, et al. Among authors: frau j. Inflamm Allergy Drug Targets. 2014;13(2):134-43. doi: 10.2174/1871528113666140513114815. Inflamm Allergy Drug Targets. 2014. PMID: 24479836 Review.
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia.
Sechi E, Puci M, Pateri MI, Zara P, Othmani S, Sotgiu S, Saddi MV, Leoni S, Fenu G, Melis M, Sotgiu G, Solla P, Cocco E, Frau J. Sechi E, et al. Among authors: frau j. Mult Scler Relat Disord. 2024 Feb 28;85:105522. doi: 10.1016/j.msard.2024.105522. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 38461730
Overexpression of the Cytokine BAFF and Autoimmunity Risk.
Steri M, Orrù V, Idda ML, Pitzalis M, Pala M, Zara I, Sidore C, Faà V, Floris M, Deiana M, Asunis I, Porcu E, Mulas A, Piras MG, Lobina M, Lai S, Marongiu M, Serra V, Marongiu M, Sole G, Busonero F, Maschio A, Cusano R, Cuccuru G, Deidda F, Poddie F, Farina G, Dei M, Virdis F, Olla S, Satta MA, Pani M, Delitala A, Cocco E, Frau J, Coghe G, Lorefice L, Fenu G, Ferrigno P, Ban M, Barizzone N, Leone M, Guerini FR, Piga M, Firinu D, Kockum I, Lima Bomfim I, Olsson T, Alfredsson L, Suarez A, Carreira PE, Castillo-Palma MJ, Marcus JH, Congia M, Angius A, Melis M, Gonzalez A, Alarcón Riquelme ME, da Silva BM, Marchini M, Danieli MG, Del Giacco S, Mathieu A, Pani A, Montgomery SB, Rosati G, Hillert J, Sawcer S, D'Alfonso S, Todd JA, Novembre J, Abecasis GR, Whalen MB, Marrosu MG, Meloni A, Sanna S, Gorospe M, Schlessinger D, Fiorillo E, Zoledziewska M, Cucca F. Steri M, et al. Among authors: frau j. N Engl J Med. 2017 Apr 27;376(17):1615-1626. doi: 10.1056/NEJMoa1610528. N Engl J Med. 2017. PMID: 28445677 Free PMC article.
204 results